Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Assets Average (2019 - 2025)

Serina Therapeutics' Assets Average history spans 6 years, with the latest figure at $10.8 million for Q2 2024.

  • For Q2 2024, Assets Average fell 13.08% year-over-year to $10.8 million; the TTM value through Jun 2024 reached $10.8 million, down 13.08%, while the annual FY2024 figure was $7.8 million, 28.53% up from the prior year.
  • Assets Average for Q2 2024 was $10.8 million at Serina Therapeutics, up from $9.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $12.4 million in Q2 2023 and bottomed at $2.3 million in Q3 2022.
  • The 5-year median for Assets Average is $4.3 million (2020), against an average of $5.9 million.
  • The largest annual shift saw Assets Average tumbled 51.41% in 2020 before it surged 433.83% in 2023.
  • A 5-year view of Assets Average shows it stood at $4.1 million in 2020, then tumbled by 31.34% to $2.8 million in 2021, then fell by 5.95% to $2.6 million in 2022, then surged by 303.47% to $10.6 million in 2023, then grew by 1.82% to $10.8 million in 2024.
  • Per Business Quant, the three most recent readings for SER's Assets Average are $10.8 million (Q2 2024), $9.9 million (Q1 2024), and $10.6 million (Q4 2023).